Will Aphria’s (TSX:APHA) Stock Tank if Q2 Earnings Miss?

If Aphria Inc (TSX:APHA)(NYSE:APHA) misses on earnings in Q2, its stock will likely tank.

edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Aphria (TSX:APHA)(NYSE:APHA) was one of the better-performing cannabis stocks of 2019. Although its stock declined in value for the year, it fell less than most of its peers thanks to two consecutive quarters of positive net income.

Aphria’s positive earnings results in 2019 were a surprise to most investors. Cannabis stocks had broadly been expected to lose money, and few expected Aphria to be the first to consistently turn profits. However, driven by the strength of its recreational sales and European distribution business, it did.

This month, we’ll get to see whether the current favourite pot stock can keep up the momentum. On January 14, the company will be releasing its earnings for the fiscal quarter ended November 2019. These earnings will show whether Aphria can keep up growth in recreational sales a year past legalization, and whether its European distribution business can continue to drive profits. If these earnings are good, Aphria shareholders may be in for a treat. If not, the stock will likely suffer the fate of its industry peers.

Why Aphria outperformed the cannabis sector last year

The main reason why Aphria outperformed other cannabis stocks last year is because it was more profitable than the rest. It notably posted two consecutive quarters of positive net income and beat earnings estimates for three out of the last four quarters.

In the cannabis industry, even a single profitable quarter is rare, so it was big news when Aphria revealed that it had achieved two in a row. Not only that, but the company’s revenue growth was among the best in the cannabis sector last year, with net revenue up 969% in Q4.

Why an earnings miss could send it tanking

The reason why an earnings miss could send Aphria tanking should be fairly obvious: it’s because of superior earnings results that Aphria outperformed in the first place.

Unlike Canopy Growth, which in 2018 went on a huge rally largely thanks to hype surrounding its Constellation Brands deal, Aphria beat its competitors because of fundamentals. It has never been the most talked-about or “buzzy” marijuana stock, and therefore can’t count on “excitement” to lift its shares.

Even after posting its two consecutive profitable quarters last year, APHA didn’t rise; it merely fell less than other marijuana stocks. If Q2 disappoints, therefore, we can expect its stock price to start falling again.

Foolish takeaway

Last year, Aphria surprised the markets with two impressive quarters, which showed not only positive earnings but also incredible growth. In a few days, we’ll get to see whether the company can pull it off again.

The markets seem to be pricing the stock in anticipation of “so-so” results, as it is still down over 52 weeks (although it is up some 22% since its $5.03 close on November 18). My advice for those considering buying APHA is to wait for the 14th and see what happens.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »